Poland – Various medicinal products – Supply of medicinal products used in drug programmes and cancer chemotherapy for the needs of the Clinics of USK-2 PUM in Szczecin

Opportunity description

1. The subject of the contract is the supply of medicinal products used in drug programmes and cancer chemotherapy for the needs of the Clinics of USK-2 PUM in Szczecin. The description of the subject of the contract and the estimated quantities of the products are included in the unit price form (Annex 2 to the SWZ, hereinafter also referred to as the FCJ). 2. The Contracting Authority requires medicinal products to be offered in accordance with the Act of 6 September 2001, Pharmaceutical Law (Journal of Laws 2001.126.1381, as amended), placed on the market and put into use in the territory of the Republic of Poland in accordance with the applicable regulations. 3. The Contracting Authority requires that the medicinal products offered be included in Annex B to the Notice of the Minister of Health on the list of reimbursed medicines (medicines available under drug programmes).).NOTE! This does not apply to task No. 6. Failure to meet the condition described in points 2 and 3 will result in rejection of the tender. 4. The Contracting Authority requires the shelf life of all products offered to be at least 12 months, calculated from the date of delivery to the Contracting Authority’s registered office. 5. The quantities of the assortment constituting the subject of the contract, specified in the annex to the contract, are estimated values used for the correct calculation of the tender price, comparison of tenders and selection of the most advantageous tender. The quantity of the assortment ordered during performance of the contract may be reduced or increased within individual assortment items, depending on the Contracting Authority’s actual needs, provided that the value of the tender and, at the same time, the Contract of the selected Contractor is not exceeded. The Contracting Authority has the right not to purchase the full quantity and assortment specified in the contract. In such a situation, the Contractors will not be entitled to any claims. The Contracting Authority has the right not to perform the full subject of the contract. Patients are qualified for drug programmes on the basis of criteria established by the Ministry of Health and the NFZ. The Contracting Authority has no real influence over them and therefore cannot declare a minimum level of contract performance. 6. Pursuant to Article 30(2) of the PZP Act, the Contracting Authority awards the contract in parts, each of which constitutes the subject of a separate procedure. 7. The contract consists of 8 tasks, a detailed description of which is included in Annex No. 2, FCJ. The Contracting Authority does not permit the submission of partial tenders. 8. The Contracting Authority does not permit the submission of variant tenders. 9.The Contracting Authority requires performance of the subject of the contract for a period of 24 months, calculated from the date of conclusion of the contract. Procedure: open. Estimated value: 14,088,218.05 PLN. Review the original TED notice for the complete requirement, lots, amendments and attachments.